drugset / Trial / NCT01406132
A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects
Non-randomizedSingle-groupOpen-label
Summary
The objective of this study is to evaluate pharmacokinetics, in particular the routes of excretion and extent of metabolism of ASP015K after a single oral dose of 14C-labeled ASP015K.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | peficitinib | Small molecule | — | Oral |
Indications
No indication recorded.